CClinicalTrials.gg
Not yet recruitingNCT06658639Updated Oct 26, 2024

Ultrasound Lipolysis Versus Cryolipolysis On Lipid Profile Levels In Centrally Obese Middle Aged Men

An interventional study of Ultrasound lipolysis and Cryolipolysis in Ultrasound Lipolysis, Cryolipolysis and Lipid Profile, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to male participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-10-26.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
Male
01

Study summary

The study compares the effects of ultrasound lipolysis and cryo lipolysis on cholesterol, triglyceride, high density lipoprotein, low density lipoprotein, body mass index, skin thickness, waist circumference, and waist hip ratio in centrally obese middle aged men. It also investigates the impact of ultrasound lipolysis on skin thickness, waist circumference, and waist hip ratio.

Read the detailed description

Obesity has become a key risk factor for the development of cardiovascular diseases and dyslipidemia. Overweight and abdominal obesity has increased in men more than in women.

For young individuals, intra-abdominal fat is the important component of the body fat for six of the eight metabolic risk factors. Intra-abdominal fat might contribute to that most patients with acute myocardial infarction at a young age are men.

Abdominal lipolysis by ultra sonic is a safe and efficacious method and can effectively decrease waist circumference, waist hip ratio and blood cholesterol.

Adding cryolipolysis to a low-calorie diet is protocol from other methods to improve the body profile, in form of body mass index, waist-to-hip ratio, as well subcutaneous fat tissues thickness, but also leads to improvement in lipid profile and liver enzymes

02

Conditions studied

  • Ultrasound Lipolysis
  • Cryolipolysis
  • Lipid Profile
  • Central Obesity

Browse trials for

03

In context

Obesity, Abdominal

274 studies on the registry are indexed under Obesity, Abdominal; 44 are open to participants now.

This study's planned enrollment of 66 is close to the median of 60 across 216 interventional studies indexed under Obesity, Abdominal.

Browse Obesity, Abdominal studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  1. Obese men with middle age range will be 40-60 years.
  2. Obese men with central obesity.
  3. Body mass index (BMI) greater than 30 Kg \m2.
  4. Waist circumference will be >94 cm.
  5. Waist to hip ratio more than 0.9

Exclusion criteria

Exclusion Criteria:

  1. Chronic respiratory disorders and cardiovascular problems.
  2. Diabetic patients.
  3. Presence of skin diseases in abdominal regions that prevent the use of ultra sound or cryolipolysis therapy.
  4. Men with kidney or liver diseases.
  5. Tumor diseases
  6. Lesions of higher center leading to obesity.
  7. History of active or chronic infectious, autoimmune disease.
  8. History of abdominal surgeries.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    ultrasound lipolysis group

    it involves 22 participants and will receive ultrasound lipolysis on abdominal area and low caloric diet treatment. abdominal area was treated for 60-minute session every 2 weeks for 3 months

    Device: Ultrasound lipolysis · Other: Low Caloric Diet

  • Active comparator
    cryolipolysis group

    it involves 22 participants and will receive cryolipolysis on abdominal area and low caloric diet treatment. Each participant underwent a cryolipolysis session on the same abdominal area every 2 weeks for 3 months

    Device: Cryolipolysis · Other: Low Caloric Diet

  • Active comparator
    low caloric diet group

    it involves 22 participants and will receive low caloric diet treatment for 3 months.

    Other: Low Caloric Diet

Interventions

  • DeviceUltrasound lipolysis

    Ultrasound lipolysis uses a Luvitra device to emit low-frequency ultrasound pulsed waves. The abdominal area is divided into two sections and the patient is placed in a comfortable supine lying position. The cavitation head is applied slowly to each segment in small circular movements. The treatment lasts 30 minutes on each side, with each session lasting 60 minutes. The same abdominal area is treated every two weeks for three months. The procedure involves cleaning the skin with alcohol cotton.

  • DeviceCryolipolysis

    The study utilized Lipocool, a cryolipolysis apparatus from Korea, with a thermoelectric cooling element. Participants were treated with thermal coupling gel on their abdomen, and the tissue was drawn into the applicator with a moderate vacuum. The device was used for 40-50 minutes, with energy extraction controlled by sensors. The system stopped cold exposure and the clinician released the vacuum. Participants underwent cryolipolysis sessions every 2 weeks for 3 months.

  • OtherLow Caloric Diet

    A low-calorie diet is a structured plan that restricts daily caloric intake, often used for weight loss. It involves consuming 1,200 to 1,500 calories daily, creating a calorie deficit. However, it requires discipline and safety. The diet is low in fat (20-25%), high in complex carbohydrates (60%), and sufficient in protein (25-50%).

06

What researchers measure

Primary outcomes

  1. assessment of change of lipid profile

    A low-calorie diet is a structured plan that restricts daily caloric intake, often used for weight loss. It involves consuming 1,200 to 1,500 calories daily, creating a calorie deficit. However, it requires discipline and safety. The diet is low in fat (20-25%), high in complex carbohydrates (60%), and sufficient in protein (25-50%).

    Time frame: at baseline and after 3 months

Secondary outcomes

  1. assessment of BMI using Body weight and height scale

    For measuring weight in kg and height in cm to calculate the body mass index (BMI) by dividing weight in kg on Height in meter square

    Time frame: at baseline and after 3 months

  2. assessment of change of skin fold thickness using skin caliper

    A caliper is used to measure suprailiac skinfold thickness where subcutaneous fat is pulled away from the muscle with the caliper tongs situated at their ends. For men, the direction of fold pulling was vertical and is taken 2 cm to the side of the umbilicus.

    Time frame: at baseline and after 3 months

  3. assessment of change of Waist Circumference using tape measurement

    A tape, resistant to stretching will be used to measure the waist circumference at the midpoint in line between the lower border of the last felt rib and the iliac crest's highest point. All patients will standing in a comfortable position, with both feet in close proximity, both arms beside the body

    Time frame: at baseline and after 3 months

  4. assessment of change of Waist Hip Ratio

    Using a non-stretchable tape, the hips is measured at the widest part of the hip bones, and the waist is measured at the midpoint in line between the lower border of the last felt rib and the iliac crest's highest point then the WHR will calculated by dividing the waist measurement by the hip measurement.

    Time frame: at baseline and after 3 months

07

Study locations

1 site
  • out-patient clinic, faculty of physical therapy, Cairo university
    Giza, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06658639
Lead sponsor
Cairo University
Responsible party
Mustafa awad ali awad (principal investigator, Cairo University) — Principal investigator
First posted
Oct 26, 2024
Start date
Nov 5, 2024 (estimated)
Primary completion
Mar 5, 2025 (estimated)
Completion
Apr 5, 2025 (estimated)
Last update
Oct 26, 2024

Study contacts

Mustafa awad Ali, physical therapist
Contact
mustafaawad279@gmail.com
01050366830

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion